Additionally, ablation of TRPA1 in APP/PS1 transgenic mice attenuated the progression of AD, improved learning and memory conditions, and reduced Aβ plaques and cytokines (Lee et al., 2016). Here, TRPA1 is linked to Alzheimer disease.